Basepoint Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Basepoint Wealth's ABBV Position: Q2 2026 in Review
Basepoint Wealth reduced its AbbVie (ABBV) stake by 1% in Q2 2026, selling an estimated $15.1K and leaving 6,960 shares worth $1.75M. The position accounts for 1% of the portfolio, ranked #14.
Basepoint Wealth first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,218 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Basepoint Wealth held 6,960 shares of AbbVie worth $1.75M as of Q2 2026.
- Basepoint Wealth sold 70 AbbVie shares in Q2 2026, an estimated $15.1K.
- AbbVie made up 1% of Basepoint Wealth's portfolio in Q2 2026, its #14 holding.
- Basepoint Wealth first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 4,218 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Basepoint Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.